Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum YKL-40 Levels is Associated With Nutritional and Oxidative Status of Hemodialysis Patients

NCT06206694 is registered in ClinicalTrials.gov with Tungs' Taichung Metroharbour Hospital as lead sponsor.

NCT NCT06206694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06206694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum YKL-40 Levels is Associated With Nutritional and Oxidative Status of Hemodialysis Patients
Lead sponsor
Tungs' Taichung Metroharbour Hospital
Phase
Observational
Overall status
Completed
Start date
May 2, 2024
Completion date
December 31, 2024
Enrollment
226 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malnutrition, oxidative stress